- Home
- GROV vs CCEL Comparison
GROV vs CCEL Comparison
Compare GROV & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROV
- CCEL
- Stock Information
- Founded
- GROV 2016
- CCEL 1989
- Country
- GROV United States
- CCEL United States
- Employees
- GROV N/A
- CCEL N/A
- Industry
- GROV Package Goods/Cosmetics
- CCEL Managed Health Care
- Sector
- GROV Consumer Discretionary
- CCEL Health Care
- Exchange
- GROV Nasdaq
- CCEL Nasdaq
- Market Cap
- GROV 51.9M
- CCEL 53.9M
- IPO Year
- GROV N/A
- CCEL 1997
- Fundamental
- Price
- GROV $1.30
- CCEL $6.48
- Analyst Decision
- GROV Buy
- CCEL
- Analyst Count
- GROV 1
- CCEL 0
- Target Price
- GROV $2.00
- CCEL N/A
- AVG Volume (30 Days)
- GROV 175.7K
- CCEL 3.6K
- Earning Date
- GROV 11-07-2024
- CCEL 10-18-2024
- Dividend Yield
- GROV N/A
- CCEL N/A
- EPS Growth
- GROV N/A
- CCEL N/A
- EPS
- GROV N/A
- CCEL N/A
- Revenue
- GROV $227,251,000.00
- CCEL $31,641,636.00
- Revenue This Year
- GROV N/A
- CCEL $3.70
- Revenue Next Year
- GROV $5.97
- CCEL $10.57
- P/E Ratio
- GROV N/A
- CCEL N/A
- Revenue Growth
- GROV N/A
- CCEL 1.93
- 52 Week Low
- GROV $1.19
- CCEL $3.67
- 52 Week High
- GROV $2.49
- CCEL $9.50
- Technical
- Relative Strength Index (RSI)
- GROV 43.69
- CCEL 50.32
- Support Level
- GROV $1.27
- CCEL $6.29
- Resistance Level
- GROV $1.43
- CCEL $6.80
- Average True Range (ATR)
- GROV 0.10
- CCEL 0.29
- MACD
- GROV -0.01
- CCEL 0.03
- Stochastic Oscillator
- GROV 17.86
- CCEL 31.07
About GROV Grove Collaborative Holdings Inc.
Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from cellular processing and cryogenic storage and it derives revenue from processing and testing fees and storage segment.